1
Total investments
1
Early stage
0
Mid stage
0
Late stage
8y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Oct 2018
Mperia Therapeutics is the CD36 Therapeutics Development Company. Lead candidates applied to macrophage-driven inflammation via CD36 receptor immuno-metabolism mediation. Showing clear efficacy in pre-clinical models for dry age-related macular degeneration (dry AMD), atherosclerosis and NASH.
Experience · 5 entries
All (5)
Investments (1)
Board (1)
2019
H
https://www.creativedestructionlab.com/
Associate at Creative Destruction Lab - Toronto
Nov 2019
2018
Board Member
Oct 2018
Mperia Therapeutics is the CD36 Therapeutics Development Company. Lead candidates applied to macrophage-driven inflammation via CD36 receptor immuno-metabolism mediation. Showing clear efficacy in pre-clinical models for dry age-related macular degeneration (dry AMD), atherosclerosis and NASH.
2017
Partner & CSO
Sep 2017
AmorChem is an early stage life science venture capital fund, which is a major supporter of Quebec’s academic innovation. The fund mainly focuses on pre-seed and seed investments with the aim of creating startup companies around groundbreaking technologies | AmorChem est un fonds d’investissement en capital de risque au stade précoce de développement, qui supporte principalement l’innovation académqiue québécoise en science de la vie. Le fonds effectue principalement des investissements de pré-démarrage et démarrage, en vue de créer des entreprises développant des percées technologiques.
2015
Vice President, Research
Oct 2015
AmorChem is an early stage life science venture capital fund, which is a major supporter of Quebec’s academic innovation. The fund mainly focuses on pre-seed and seed investments with the aim of creating startup companies around groundbreaking technologies | AmorChem est un fonds d’investissement en capital de risque au stade précoce de développement, qui supporte principalement l’innovation académqiue québécoise en science de la vie. Le fonds effectue principalement des investissements de pré-démarrage et démarrage, en vue de créer des entreprises développant des percées technologiques.
2013
Director, Project Management
Jan 2013
AmorChem is an early stage life science venture capital fund, which is a major supporter of Quebec’s academic innovation. The fund mainly focuses on pre-seed and seed investments with the aim of creating startup companies around groundbreaking technologies | AmorChem est un fonds d’investissement en capital de risque au stade précoce de développement, qui supporte principalement l’innovation académqiue québécoise en science de la vie. Le fonds effectue principalement des investissements de pré-démarrage et démarrage, en vue de créer des entreprises développant des percées technologiques.